Compile Data Set for Download or QSAR
Report error Found 126 Enz. Inhib. hit(s) with all data for entry = 50006784
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503340BDBM50503340(CHEMBL4468636)
Affinity DataIC50: 2nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503331BDBM50503331(CHEMBL4522687)
Affinity DataIC50: 2nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503336BDBM50503336(CHEMBL4437377)
Affinity DataIC50: 2nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180052BDBM180052(US9133148, 9aq | US12378231, Example ABX-1431)
Affinity DataIC50: 2.20nMAssay Description:Inhibition of MGLL in human intact PC3 cells preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 179948BDBM179948(US9133148, 2l)
Affinity DataIC50: 3nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180039BDBM180039(US9133148, 9ad)
Affinity DataIC50: 3.5nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503334BDBM50503334(CHEMBL4468639)
Affinity DataIC50: 4nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503335BDBM50503335(CHEMBL4450649)
Affinity DataIC50: 4nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180078BDBM180078(US9133148, 10g)
Affinity DataIC50: 5nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503339BDBM50503339(CHEMBL4469632)
Affinity DataIC50: 6nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503336BDBM50503336(CHEMBL4437377)
Affinity DataIC50: 8nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503333BDBM50503333(CHEMBL4539731)
Affinity DataIC50: 9nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503327BDBM50503327(CHEMBL4435014)
Affinity DataIC50: 11nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503342BDBM50503342(CHEMBL4436074)
Affinity DataIC50: 11nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503344BDBM50503344(CHEMBL4439400)
Affinity DataIC50: 12nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 179938BDBM179938(US9133148, 2b)
Affinity DataIC50: 12nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503333BDBM50503333(CHEMBL4539731)
Affinity DataIC50: 14nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180052BDBM180052(US9133148, 9aq | US12378231, Example ABX-1431)
Affinity DataIC50: 14nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503331BDBM50503331(CHEMBL4522687)
Affinity DataIC50: 15nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503337BDBM50503337(CHEMBL4517565)
Affinity DataIC50: 15nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503345BDBM50503345(CHEMBL4550205)
Affinity DataIC50: 17nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503340BDBM50503340(CHEMBL4468636)
Affinity DataIC50: 17nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503334BDBM50503334(CHEMBL4468639)
Affinity DataIC50: 17nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180033BDBM180033(US9133148, 9x)
Affinity DataIC50: 17nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180029BDBM180029(US9133148, 9t)
Affinity DataIC50: 18nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180076BDBM180076(US9133148, 10e)
Affinity DataIC50: 20nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503338BDBM50503338(CHEMBL4584757)
Affinity DataIC50: 24nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503335BDBM50503335(CHEMBL4450649)
Affinity DataIC50: 24nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180012BDBM180012(US9133148, 9c)
Affinity DataIC50: 25nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetPlatelet-activating factor acetylhydrolase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 179948BDBM179948(US9133148, 2l)
Affinity DataIC50: 26nMAssay Description:Inhibition of PLA2G7 derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503329BDBM50503329(CHEMBL4546592)
Affinity DataIC50: 26nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180052BDBM180052(US9133148, 9aq | US12378231, Example ABX-1431)
Affinity DataIC50: 27nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180035BDBM180035(US9133148, 9z)
Affinity DataIC50: 27nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180075BDBM180075(US9133148, 10d)
Affinity DataIC50: 28nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503337BDBM50503337(CHEMBL4517565)
Affinity DataIC50: 29nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180035BDBM180035(US9133148, 9z)
Affinity DataIC50: 34nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503344BDBM50503344(CHEMBL4439400)
Affinity DataIC50: 48nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503343BDBM50503343(CHEMBL4434763)
Affinity DataIC50: 51nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503330BDBM50503330(CHEMBL4529300)
Affinity DataIC50: 51nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180012BDBM180012(US9133148, 9c)
Affinity DataIC50: 59nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503327BDBM50503327(CHEMBL4435014)
Affinity DataIC50: 66nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 179946BDBM179946(US9133148, 2j)
Affinity DataIC50: 69nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoacylglycerol lipase ABHD6(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503339BDBM50503339(CHEMBL4469632)
Affinity DataIC50: 91nMAssay Description:Inhibition of ABHD6 derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetPlatelet-activating factor acetylhydrolase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503339BDBM50503339(CHEMBL4469632)
Affinity DataIC50: 93nMAssay Description:Inhibition of PLA2G7 derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180042BDBM180042(US9133148, 9ag)
Affinity DataIC50: 98nMAssay Description:Inhibition of MGLL derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoacylglycerol lipase ABHD6(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503342BDBM50503342(CHEMBL4436074)
Affinity DataIC50: 99nMAssay Description:Inhibition of ABHD6 derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503343BDBM50503343(CHEMBL4434763)
Affinity DataIC50: 120nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoacylglycerol lipase ABHD6(Human)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 180076BDBM180076(US9133148, 10e)
Affinity DataIC50: 130nMAssay Description:Inhibition of ABHD6 derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503345BDBM50503345(CHEMBL4550205)
Affinity DataIC50: 130nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50503330BDBM50503330(CHEMBL4529300)
Affinity DataIC50: 159nMAssay Description:Inhibition of MGLL derived from mouse brain homogenates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 126 total ) | Next | Last >>
Jump to: